Weiss Multi-Strategy Advisers’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-50,000	Closed	-$1.82M	–	687
2016 Q4	$1.82M	Buy	50,000 +18,000	+56%	+$637K	0.09%	215
2016 Q3	$1.22M	Buy	+32,000	New	+$473K	0.08%	273

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CLCD Position: Q1 2017 in Review

Weiss Multi-Strategy Advisers sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 50,000 shares — an estimated $1.82M sold.

Weiss Multi-Strategy Advisers first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $1.82M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Weiss Multi-Strategy Advisers reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 50,000 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $1.82M.
Weiss Multi-Strategy Advisers first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
Weiss Multi-Strategy Advisers's CoLucid Pharmaceuticals, Inc. position peaked at $1.82M in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2017, filed 15 May 2017.